QUICKLINKS AND VIEW OPITONS

EMAIL THE ARTICLE BELOW TO A FRIEND

Email address of your friend:
(For example: myfriend@aol.com)

Your name:
(Example: Lori Jones)

Your email address:
(For example: lorijones@aol.com)

Subject:

Message:
Here is a summary of article I thought you might be interested in. 12 serious heart problems deleted from diabetes drug study of rosiglitazone (Avandia), Dr. Gotzsche Prof. Peter Gotzsche, MD notes that the RECORD trial of the diabetes drug rosiglitazone (Avandia) was terribly manipulated by GlaxoSmithKline. An article published in the New York Times on July 9, 2010 titled, “Caustic Government Report Deals Blow to Diabetes Drug” revealed that Dr. Thomas Marciniak, a reviewer at the US Food and Drug Administration (FDA), found a dozen instances in which patients taking Rosiglitazone (Avandia) suffered serious heart problems that were not counted in the study’s tally of adverse events. The article also notes that “It [ Rosiglitazone (Avandia) ] has been shown to increase the risks of bone fractures and to cause swelling that can lead to heart failure and eye problems.” The article also notes that “Dr. Jerome P. Kassirer, a former editor of The New England Journal, said the Record trial raised the question “whether the entire system is corrupt.”” Here is the link to the entire article. http://www.fatnews.com/index.php/5694

12 serious heart problems deleted from diabetes drug study of rosiglitazone (Avandia), Dr. Gotzsche

Prof. Peter Gotzsche, MD notes that the RECORD trial of the diabetes drug rosiglitazone (Avandia) was terribly manipulated by GlaxoSmithKline.

An article published in the New York Times on July 9, 2010 titled, “Caustic Government Report Deals Blow to Diabetes Drug” revealed that Dr. Thomas Marciniak, a reviewer at the US Food and Drug Administration (FDA), found a dozen instances in which patients taking Rosiglitazone (Avandia) suffered serious heart problems that were not counted in the study’s tally of adverse events.

The article also notes that “It [ Rosiglitazone (Avandia) ] has been shown to increase the risks of bone fractures and to cause swelling that can lead to heart failure and eye problems.”

The article also notes that “Dr. Jerome P. Kassirer, a former editor of The New England Journal, said the Record trial raised the question “whether the entire system is corrupt.””

Posted by: Admin2 on Feb 13, 2015 - 5:31 pm

© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.

SEARCH THIS SITE

CONTACT US

CATEGORIES

ARCHIVES

ARCHIVE SUMMARY

RSS / XML

QUICKLINKS AND VIEW OPITONS

EMAIL THE ARTICLE BELOW TO A FRIEND

12 serious heart problems deleted from diabetes drug study of rosiglitazone (Avandia), Dr. Gotzsche